The MAPK pathway across different malignancies: A new perspective
National Cancer Institute · Center for Cancer Research · +1 more institution
Abstract
The mitogen-activated protein kinase/extracellular signal-regulated (MAPK/ERK) pathway is activated by upstream genomic events and/or activation of multiple signaling events in which information coalesces at this important nodal pathway point. This pathway is tightly regulated under normal conditions by phosphatases and bidirectional communication with other pathways, like the protein kinase B/mammalian target of rapamycin (AKT/m-TOR) pathway. Recent evidence indicates that the MAPK/ERK signaling node can function as a tumor suppressor as well as the more common pro-oncogenic signal. The effect that predominates depends on the intensity of the signal and the context or tissue in which the signal is aberrantly…
Citation impact
- FWCI
- 15.93
- Percentile
- 100%
- References
- 101
Authors
4- MBMauricio BurottoCorresponding
National Cancer Institute, Center for Cancer Research
- VLVictoria L. Chiou
National Cancer Institute, Center for Cancer Research
- JLJung‐Min Lee
National Cancer Institute, Center for Cancer Research
- ECElise C. Kohn
National Cancer Institute, National Cancer Institute, Center for Cancer Research
Topics & keywords
- MAPK/ERK pathway
- Cancer research
- Signal transduction
- Kinase
- Protein kinase B
- Medicine
- Oncogene
- Cancer
- Good health and well-being